Bitter agonists that activate type II taste receptors (TAS2Rs) have been found to modulate adipocyte differentiation and depletion of the α-subunit of the gustatory G protein gustducin protects against obesity on high fat diet with increased BAT activity [48]. The gene discussed is GNAT3; the disease is obesity disorder.